Material Transfer Agreement Mta For Human Biosamples Form
Use a Template Material Transfer Agreement MTA For Human Biosamples template to make your document workflow more streamlined.
What this human biosample agreement does
A Material Transfer Agreement for human biosamples is a written agreement that controls how one organization provides human-derived specimens to another for defined research or testing purposes. It identifies the material, permitted uses, custody, confidentiality, privacy responsibilities, publication rights, intellectual property terms, and disposal or return obligations. The sending and receiving institutions approve those terms before transfer. With signNow, a team can upload the agreement, place fields for each authorized signer, route it in order, capture an audit trail, and retain the completed record.
Organizations that use these agreements
The form is most useful when multiple institutions must document custody, permitted research, privacy duties, and approvals before human biosamples move between parties.
A university biobank can document specimen identifiers, approved research purposes, transfer restrictions, consent limitations, and receiving-investigator signatures before releasing human biosamples. A hospital research department can coordinate clinical investigators, privacy reviewers, sponsored-research officers, and external laboratories while preserving the final agreement and its signing history. A biotechnology enterprise can standardize agreements across research sites, sponsors, and contract laboratories, using controlled templates and role-based approvals for recurring human-biosample transfers.
These tasks are executed by both individual contributors and centralized administrators depending on organizational policy and required controls.
Key features for human biosample transfers
Material Transfer Agreement workflows combine structured terms, accountable approvals, secure signing, and retained records for research organizations handling human biosamples.
Reusable fields
Upload the agreement once, then use reusable fields for sample descriptions, permitted uses, restrictions, signers, dates, and institutional approvals. This reduces repeated manual formatting across research transfers.
Role-based routing
Route the agreement to institutional officials, principal investigators, sponsors, or receiving laboratories in a defined signing order. Each signer sees only the fields assigned to that role.
Audit trail
Capture signatures, timestamps, signer actions, and document history in an audit trail. The record helps teams demonstrate who approved the biosample transfer and when.
Approved templates
Use signNow templates to preserve approved language about human biosamples, confidentiality, storage, data sharing, publications, and return or destruction obligations.
Data protection
Protect sensitive research and participant information with encryption in transit and at rest, supported by TLS and AES-256 controls.
Secure storage
Connect completed agreements with Google Drive, Box, Egnyte, or institutional workflows so authorized teams can retrieve signed records without paper handling.
How the agreement workflow works
Move the human biosample agreement from document preparation through verified fields, institutional approvals, signatures, and controlled record storage.
Upload: Upload the agreement Review fields: Auto-detect fields, then verify sample and approval fields. Route signers: Add institutional and receiving-party signers in order. Store record: Collect signatures and retain the signed agreement with its audit trail.
Complete the agreement in four steps
Use this sequence to prepare, route, sign, and retain a Material Transfer Agreement for human biosamples.
Upload document:
Upload the approved agreement to signNow. Verify fields:
Check detected fields for samples, terms, and dates. Add signers:
Add authorized institutional and receiving signers. Complete record:
Send, monitor, and download the completed record.
Best ROI. Our customers achieve an average 7x ROI within the first six months.
Scales with your use cases. From SMBs to mid-market, airSlate SignNow delivers results for businesses of all sizes.
Intuitive UI and API. Sign and send documents from your apps in minutes.
Recommended agreement workflow setup
Configure the signing process around authorized identities, institutional review, protected information, and a reproducible record of every approval.
| Setting | Recommendation |
|---|---|
| Authentication method | Email verification with SMS code |
| Signature type | Electronic signature with signer intent |
| Audit trail | Capture timestamps and signer actions |
| Document retention | Six years for PHI records under 45 CFR 164.530(j) |
| Encryption | TLS 1.2/1.3 and AES-256 encryption in transit and at rest. |
What the audit trail records
The audit trail documents the signing event separately from the agreement’s substantive research terms, creating a traceable record of execution and handling.
Authenticate signer:
Timestamp event:
Log actions:
Seal history:
Complete document:
Export record:
Privacy and disclosure pitfalls
Including participant identifiers in the agreement can expose personal information beyond the people who need it for transfer administration. A consent form may authorize one research purpose while the agreement permits another, creating a mismatch that requires institutional review. Unassigned signers or broad folder permissions can expose biosample terms, participant information, or unpublished research details to unauthorized users. Leaving storage, destruction, return, or secondary-use terms vague can create disputes after the receiving laboratory obtains the material.
Security for biosample agreements
Data in transit:
Data at rest:
Security certification:
Management standard:
Health information:
Regulated records:
Recordkeeping practices for biosample transfers
Clear terms and disciplined records help research teams demonstrate what was transferred, who approved it, and how the agreement governed later use.
Define material and permitted use
Assign every required approval
Retain the agreement and audit trail
Document custody and disposal duties
Retention schedule for agreement records
Retention depends on the record category, PHI involvement, institutional policy, sponsor terms, and applicable state requirements.
Six years: PHI records
Policy-defined: research records
Policy-defined: consent records
Contract-defined: sponsor records
State-specific: longer periods
Documents outside this agreement workflow
State requirement
Wills and codicils
Family law orders
Real-estate deeds
Examples for research organizations
Healthcare and biobank teams can adapt the workflow to coordinate approvals while keeping human-biosample terms and privacy duties visible.
Fertility healthcare
Fertility Centers of Illinois uses signNow in a healthcare setting where APIs and responsive support help coordinate document workflows involving sensitive patient-related operations.
- Healthcare research coordination
The customer story identifies Fertility Centers of Illinois as a signNow user and specifically highlights its API and support experience. For a human-biosample agreement, an organization would still need to define authorized uses, protect PHI, obtain required institutional approvals, and confirm that its BAA and privacy controls are appropriate.
University biobank
A university biobank can use a controlled signNow template to route human-biosample terms among investigators, research administrators, sponsors, and receiving laboratories.
- Defined research purpose
- Recorded institutional approvals
This anonymized scenario illustrates a document workflow rather than a named customer result. The agreement should identify the material and permitted purpose, address confidentiality and disposal, and preserve the signed document with its audit trail so the institution can demonstrate authorization for the transfer.
Troubleshooting biosample agreement workflows
These answers address the document, signer, privacy, and recordkeeping issues that arise when human biosample agreements move through signNow.
Upload the source agreement again in a readable PDF format, then check whether signNow detects the intended fields. If automatic detection misses a biosample identifier, permitted-use clause, or approval field, place the field manually and assign it to the correct signer before sending.
A signNow Business plan includes templates, audit trails, and legally binding eSignatures. If the workflow needs bulk sending, Business Premium adds bulk send; select the plan according to document volume and routing requirements rather than assuming every plan has identical features.
For human biosamples containing protected health information, signNow states that HIPAA compliance requires a business associate agreement. Confirm that the BAA and your institutional privacy procedures are in place before transmitting PHI through the workflow.
Review signer roles and routing order before sending. Principal investigators, institutional officials, sponsors, and receiving laboratories may have different approval responsibilities; correcting an incorrectly assigned field before signature prevents an incomplete agreement record.
SignNow captures timestamps, document history, and signer actions in an audit trail. Export and retain the completed agreement and audit record together according to your institution’s research, privacy, and records-management policy.
ESIGN and UETA generally recognize electronic signatures when intent, consent, attribution, and record retention are established. They do not replace human-subjects review, institutional approvals, consent requirements, or state-specific research obligations.
Key performance indicators that demonstrate SignNow's proven track record.
BE READY TO GET MORE
Get this form now!
If you believe that this page should be taken down, please follow our DMCA take-down process.